TrialBone marrow transplantation2023

Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276).

Fei Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.